The Nifty extended its losing streak with a sixth consecutive decline, slipping below the 25,000 support level amid broad-based selling, especially in pharma and IT stocks. Analysts warn of further downside if 24,500 breaks, though a recovery remains possible. Stock recommendations include Ashok Leyland, Dr Agarwal’s Health Care, Dixon, and Anant Raj.
US Stock Market: Goldman Sachs raises S&P 500 target to 8,000 on AI-driven earnings optimism
Goldman Sachs has boosted its S&P 500 target for 2026 to 8,000. This optimistic outlook is driven by strong corporate earnings and continued investment in